131 related articles for article (PubMed ID: 7802667)
1. Participation of diacylglycerol kinase in mitogenic signal transduction induced by platelet-derived growth factor in vascular smooth muscle cells.
Inui H; Kondo T; Konishi F; Kitami Y; Inagami T
Biochem Biophys Res Commun; 1994 Dec; 205(2):1338-44. PubMed ID: 7802667
[TBL] [Abstract][Full Text] [Related]
2. Differences in signal transduction between platelet-derived growth factor (PDGF) alpha and beta receptors in vascular smooth muscle cells. PDGF-BB is a potent mitogen, but PDGF-AA promotes only protein synthesis without activation of DNA synthesis.
Inui H; Kitami Y; Tani M; Kondo T; Inagami T
J Biol Chem; 1994 Dec; 269(48):30546-52. PubMed ID: 7982973
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase D activation in PDGF-stimulated vascular smooth muscle cells.
Randall RW; Spacey GD; Bonser RW
Biochem Soc Trans; 1993 Nov; 21(4):352S. PubMed ID: 8131933
[No Abstract] [Full Text] [Related]
4. Potentiation of mitogenic activity of platelet-derived growth factor by physiological concentrations of insulin via the MAP kinase cascade in rat A10 vascular smooth muscle cells.
Yamada H; Tsushima T; Murakami H; Uchigata Y; Iwamoto Y
Int J Exp Diabetes Res; 2002; 3(2):131-44. PubMed ID: 11991199
[TBL] [Abstract][Full Text] [Related]
5. Activation of phospholipase D induced by platelet-derived growth factor is dependent upon the level of phospholipase C-gamma 1.
Lee YH; Kim HS; Pai JK; Ryu SH; Suh PG
J Biol Chem; 1994 Oct; 269(43):26842-7. PubMed ID: 7929422
[TBL] [Abstract][Full Text] [Related]
6. Regulatory effects of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells.
Koyama N; Morisaki N; Saito Y; Yoshida S
J Biol Chem; 1992 Nov; 267(32):22806-12. PubMed ID: 1331068
[TBL] [Abstract][Full Text] [Related]
7. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells.
Schönherr E; Kinsella MG; Wight TN
Arch Biochem Biophys; 1997 Mar; 339(2):353-61. PubMed ID: 9056268
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase is involved in angiotensin II-stimulated phospholipase D activation in aortic smooth muscle cells: function of Ca2+ influx.
Suzuki A; Shinoda J; Oiso Y; Kozawa O
Atherosclerosis; 1996 Mar; 121(1):119-27. PubMed ID: 8678916
[TBL] [Abstract][Full Text] [Related]
9. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells.
Leduc I; Haddad P; Giasson E; Meloche S
Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.
Weber H; Taylor DS; Molloy CJ
J Clin Invest; 1994 Feb; 93(2):788-98. PubMed ID: 7509348
[TBL] [Abstract][Full Text] [Related]
12. Genistein but not staurosporine can inhibit the mitogenic signal evoked by lithium in rat thyroid cells (FRTL-5).
Takano T; Takada K; Tada H; Nishiyama S; Amino N
J Endocrinol; 1994 Nov; 143(2):221-6. PubMed ID: 7829987
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
Shimokado K; Umezawa K; Ogata J
Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
[TBL] [Abstract][Full Text] [Related]
14. ATP- and EGF-stimulated phosphatidulinositol synthesis by two different pathways, phospholipase D and diacylglycerol kinase, in A-431 epidermoid carcinoma cells.
Hosoi K; Shioda Y; Ueha T; Atsumi T; Sugita K; Kurihara K
Biochem Cell Biol; 1996; 74(2):197-209. PubMed ID: 9213428
[TBL] [Abstract][Full Text] [Related]
15. A tyrosine kinase regulates alpha-adrenoceptor-stimulated contraction and phospholipase D activation in the rat aorta.
Jinsi A; Paradise J; Deth RC
Eur J Pharmacol; 1996 Apr; 302(1-3):183-90. PubMed ID: 8791006
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms of phospholipase D activation and attenuation utilized by different mitogens in NIH-3T3 fibroblasts.
Ben-Av P; Eli Y; Schmidt US; Tobias KE; Liscovitch M
Eur J Biochem; 1993 Jul; 215(2):455-63. PubMed ID: 8344313
[TBL] [Abstract][Full Text] [Related]
17. Transduction pathways for growth stimulatory and inhibitory actions of vasoactive agents.
Newby AC; Assender JW; Evans MA; Lim K; Bennett MR; Evan GI
Exp Nephrol; 1994; 2(2):94-100. PubMed ID: 7521776
[No Abstract] [Full Text] [Related]
18. Phospholipase D mimics platelet-derived growth factor as a competence factor in vascular smooth muscle cells.
Kondo T; Inui H; Konishi F; Inagami T
J Biol Chem; 1992 Nov; 267(33):23609-16. PubMed ID: 1429702
[TBL] [Abstract][Full Text] [Related]
19. Cytosolic Ca2+ transients are not required for platelet-derived growth factor to induce cell cycle progression of vascular smooth muscle cells in primary culture. Actions of tyrosine kinase.
Kobayashi S; Nishimura J; Kanaide H
J Biol Chem; 1994 Mar; 269(12):9011-8. PubMed ID: 7510699
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase D is involved in oxidative stress-induced migration of vascular smooth muscle cells via tyrosine phosphorylation and protein kinase C.
Kim J; Min G; Bae YS; Min DS
Exp Mol Med; 2004 Apr; 36(2):103-9. PubMed ID: 15150437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]